Effect of Mature Neutrophil PR3 on CFU-GM in S-Phase in Two Experiments
PR3 (ng/mL) . | S-phase (%) . | |
---|---|---|
Exp No. 1 . | Exp No. 2 . | |
Medium control | 34.8 | 34.7 |
15 | 29.8 | ND |
30 | 28.9 | 36.0 |
60 | 41.6 | 36.3 |
125 | 26.5* | 41.5 |
250 | 27.5* | 31.5 |
RBL/PR3 20 ng/mL | 18.6* | 19.9* |
PR3 (ng/mL) . | S-phase (%) . | |
---|---|---|
Exp No. 1 . | Exp No. 2 . | |
Medium control | 34.8 | 34.7 |
15 | 29.8 | ND |
30 | 28.9 | 36.0 |
60 | 41.6 | 36.3 |
125 | 26.5* | 41.5 |
250 | 27.5* | 31.5 |
RBL/PR3 20 ng/mL | 18.6* | 19.9* |
There were 204 ± 5 and 268 ± 32 colonies per dish in the controls of exp no. 1 and exp no. 2, respectively. CM of PR3 transfectant RBL cells (RBL/PR3) containing 20 ng/mL PR3 was included as positive control.
Abbreviation: ND, not done.
Denotes significant reduction of CFU-GM in S-phase (P < .05).